AU6338399A - Test kit for diagnosis of borrelia infection and novel borrelia antigens for thedevelopment of vaccines - Google Patents

Test kit for diagnosis of borrelia infection and novel borrelia antigens for thedevelopment of vaccines

Info

Publication number
AU6338399A
AU6338399A AU63383/99A AU6338399A AU6338399A AU 6338399 A AU6338399 A AU 6338399A AU 63383/99 A AU63383/99 A AU 63383/99A AU 6338399 A AU6338399 A AU 6338399A AU 6338399 A AU6338399 A AU 6338399A
Authority
AU
Australia
Prior art keywords
borrelia
thedevelopment
vaccines
diagnosis
test kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63383/99A
Inventor
Michael dr. Kramer
Markus Simon
Reinhard Wallich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU6338399A publication Critical patent/AU6338399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
AU63383/99A 1998-10-13 1999-10-12 Test kit for diagnosis of borrelia infection and novel borrelia antigens for thedevelopment of vaccines Abandoned AU6338399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19847142 1998-10-13
DE19847142A DE19847142A1 (en) 1998-10-13 1998-10-13 Diagnosing borelliosis by detecting specific antibodies, using new Borellia antigens expressed preferentially during infection and also useful as immunogens in vaccines
PCT/EP1999/007651 WO2000022134A2 (en) 1998-10-13 1999-10-12 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines

Publications (1)

Publication Number Publication Date
AU6338399A true AU6338399A (en) 2000-05-01

Family

ID=7884307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63383/99A Abandoned AU6338399A (en) 1998-10-13 1999-10-12 Test kit for diagnosis of borrelia infection and novel borrelia antigens for thedevelopment of vaccines

Country Status (3)

Country Link
AU (1) AU6338399A (en)
DE (1) DE19847142A1 (en)
WO (1) WO2000022134A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1726960B1 (en) * 2005-05-23 2009-03-11 Viramed Biotech AG Carriers and methods for the detection of anti-Borrelia-antibodies and kit for the use in the diagnosis of Lyme-Borrelia infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433690T2 (en) * 1993-11-01 2005-03-10 Brookhaven Science Associates CHIMERIC PROTEINS CONTAINING BORRELIA POLYPEPTIDE USES THEREOF

Also Published As

Publication number Publication date
WO2000022134A3 (en) 2000-08-24
WO2000022134A2 (en) 2000-04-20
DE19847142A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
AU5070999A (en) (streptococcus suis) vaccines and diagnostic tests
AU1219100A (en) Method and kit for rapid preparation of autologous tissue medical devices
AU2002249819A1 (en) Measurement testing of blood specimens
AU2001278076A1 (en) Bstp-5 proteins and related reagents and methods of use thereof
IL156618A0 (en) Crystals of whole antibodies and fragments thereof, methods for the preparation thereof and diagnostic kits utilizing the same
AU2322099A (en) Multiplexed analysis of clinical specimens apparatus and methods
AU4640400A (en) Analysis of differential protein expression
AU4036800A (en) Devices and methods for collecting fecal antigen specimens
AU7262198A (en) Methods and reagents for rapid diagnosis of dengue virus infection
AU6184396A (en) Solid oral diagnostic test meal and methods of use thereof
AU5252698A (en) Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
AU2001275007A1 (en) Methods of testing materials
EP0934427A4 (en) Rh blood group antigen compositions and methods of use
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU9302898A (en) Methods of measuring gene expression using wax-embedded tissue specimens
AU6709496A (en) Reagent for examining agglutination of virus and kit for virus examination
AU3453700A (en) Sample examining instrument and wiping-out examining instrument
AU8898198A (en) Methods of identifying biological agent compositions
AU6338399A (en) Test kit for diagnosis of borrelia infection and novel borrelia antigens for thedevelopment of vaccines
AU4036495A (en) Device and test kit for the detection of AIDS
AU3460800A (en) Method of bleaching blood samples, diagnostic method and diagnostic kit using the same
GB0027196D0 (en) Contamination-free transfer of biological specimens
EP1003841A4 (en) Establishment of hhv-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting hhv-8 infection
AU4985900A (en) Secreted proteins of (mycobacterium tuberculosis) and their use as vaccines and diagnostic reagents
AU2001243640A1 (en) Compositions and methods for simultaneous detection of multiple biological entities

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase